Mentice AB (STO: MNTC) announces that the company will present its Year-End Q4-2025 interim report for the period October – December via a webcast conference call on February 26, 2026, at 10:00 CET.

Mentice AB (STO: MNTC) announces that the company will present its Year-End Q4-2025 interim report for the period October – December via a webcast conference call on February 26, 2026, at 10:00 CET.

The webcast will feature presentations from CEO Frans Venker and CFO Ulrika Drotz, who will share key insights into the company’s financial results and strategic progress.

The session will conclude with a live Q&A, moderated by Rikard Engberg, Analyst at DNB Carnegie. The presentation will be conducted in English, and participants are encouraged to register in advance.

For registration details and access to the webcast, please visit the DNB Carnegie registration site here.

For more information:Alexandra Deising, Sr Marketing Manager, MenticeE-post: alexandra.deising@mentice.comMobile: +46 703 093 524

About MenticeMentice (STO: MNTC) is the world leader in proficiency based simulation solutions for image guided interventional therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are just some of the clinical areas covered by our solutions. Learn more about the features and benefits of Mentice solutions at: www.mentice.com

Marketplace| Nasdaq First North Premium Growth Market, Stockholm | Ticker symbol MNTCCertified Adviser| FNCA Sweden AB

AttachmentsMentice to Present the Company's Year-End Q4 Report 2025 via Webcast